Cargando…

Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant

[Image: see text] The emergence of new SARS-CoV-2 Omicron variant of concern (OV) has exacerbated the COVID-19 pandemic because of a large number of mutations in the spike protein, particularly in the receptor-binding domain (RBD), resulting in highly contagious and/or vaccine-resistant strains. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jawad, Bahaa, Adhikari, Puja, Podgornik, Rudolf, Ching, Wai-Yim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063111/ https://www.ncbi.nlm.nih.gov/pubmed/35481766 http://dx.doi.org/10.1021/acs.jpclett.2c00423

Ejemplares similares

Mutations of Omicron Variant at the Interface of the Receptor Domain Motif and Human Angiotensin-Converting Enzyme-2
por: Adhikari, Puja, et al.
Publicado: (2022)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Quantum Chemical Computation of Omicron Mutations Near Cleavage Sites of the Spike Protein
por: Adhikari, Puja, et al.
Publicado: (2022)

Towards Quantum-Chemical Level Calculations of SARS-CoV-2 Spike Protein Variants of Concern by First Principles Density Functional Theory
por: Ching, Wai-Yim, et al.
Publicado: (2023)

Ultra-large-scale ab initio quantum chemical computation of bio-molecular systems: The case of spike protein of SARS-CoV-2 virus
por: Ching, Wai-Yim, et al.
Publicado: (2021)

Delta Variant with P681R Critical Mutation Revealed by Ultra-Large Atomic-Scale Ab Initio Simulation: Implications for the Fundamentals of Biomolecular Interactions
por: Adhikari, Puja, et al.
Publicado: (2022)

First-Principles Simulation of Dielectric Function in Biomolecules
por: Adhikari, Puja, et al.
Publicado: (2021)

Solvent Effect on the Structure and Properties of RGD Peptide (1FUV) at Body Temperature (310 K) Using Ab Initio Molecular Dynamics
por: Baral, Khagendra, et al.
Publicado: (2021)

Computational Design of Miniproteins as SARS-CoV-2 Therapeutic Inhibitors
por: Jawad, Bahaa, et al.
Publicado: (2022)

Amino acid interacting network in the receptor-binding domain of SARS-CoV-2 spike protein
por: Adhikari, Puja, et al.
Publicado: (2020)

An Insight Based on Computational Analysis of the Interaction between the Receptor-Binding Domain of the Omicron Variants and Human Angiotensin-Converting Enzyme 2
por: Celik, Ismail, et al.
Publicado: (2022)

Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
por: Junker, Daniel, et al.
Publicado: (2022)

Improved Binding Affinity of Omicron’s Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence
por: Kumar, Rajender, et al.
Publicado: (2022)

SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins
por: Matthews, Alicia M., et al.
Publicado: (2022)

Omicron variant and change of electrostatic interactions between receptor binding domain of severe acute respiratory syndrome coronavirus 2 with the angiotensin-converting enzyme 2 receptor
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2
por: Li, Hai-yun, et al.
Publicado: (2022)

Dynamics of the interaction between the receptor-binding domain of SARS-CoV-2 Omicron (B.1.1.529) variant and human angiotensin-converting enzyme 2
por: Antony, Priya, et al.
Publicado: (2022)

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
por: Esparza, Thomas J., et al.
Publicado: (2020)

Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain
por: Lupala, Cecylia Severin, et al.
Publicado: (2022)

Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2
por: Li, Hai-yun, et al.
Publicado: (2022)

Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2
por: Wang, Ting, et al.
Publicado: (2022)

Distinctive Features of the XBB.1.5 and XBB.1.16 Spike Protein Receptor-Binding Domains and Their Roles in Conformational Changes and Angiotensin-Converting Enzyme 2 Binding
por: Sharma, Tej, et al.
Publicado: (2023)

Impact of Thiol–Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor
por: Hati, Sanchita, et al.
Publicado: (2020)

Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
por: Borkotoky, Subhomoi, et al.
Publicado: (2022)

Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants
por: Chakraborty, Sandipan, et al.
Publicado: (2022)

In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2
por: Jafary, Farzaneh, et al.
Publicado: (2021)

A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
por: Coghi, Paolo, et al.
Publicado: (2021)

S373P Mutation Stabilizes the Receptor-Binding Domain of the Spike Protein in Omicron and Promotes Binding
por: Zheng, Bin, et al.
Publicado: (2023)

Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2
por: Wang, Meng, et al.
Publicado: (2023)

Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant
por: Antony, Priya, et al.
Publicado: (2021)

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
por: Chen, Xiangyu, et al.
Publicado: (2020)

Indigo plant leaf extract inhibits the binding of SARS-CoV-2 spike protein to angiotensin-converting enzyme 2
por: Hagiyama, Man, et al.
Publicado: (2022)

D3AI-Spike: A deep learning platform for predicting binding affinity between SARS-CoV-2 spike receptor binding domain with multiple amino acid mutations and human angiotensin-converting enzyme 2
por: Han, Jiaxin, et al.
Publicado: (2022)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
por: Clayton, Daniel, et al.
Publicado: (2015)

Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence
por: Laurini, Erik, et al.
Publicado: (2021)

Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells
por: Senthil Kumar, K. J., et al.
Publicado: (2020)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Prevalence of an angiotensin-converting enzyme gene variant in dogs
por: Adin, D. B., et al.
Publicado: (2021)

Omicron variant receptor-binding domain phylogenetics and molecular dynamics
por: Kandeel, Mahmoud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8lhg7hg308trm4ot4b915ddfcm